John William S, Martin Thomas J, Nader Michael A
Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Neuropsychopharmacology. 2017 Jun;42(7):1522-1530. doi: 10.1038/npp.2017.2. Epub 2017 Jan 6.
Reinforcing effects of Δ-tetrahydrocannabinol (THC), the primary active ingredient in marijuana, as assessed with self-administration (SA), has only been established in New World primates (squirrel monkeys). The objective of this study was to investigate some experimental factors that may enhance intravenous SA of THC and the cannabinoid receptor (CBR) agonist CP 55 940 in Old World monkeys (rhesus and cynomolgus), a species that has been used extensively in biomedical research. In one experiment, male rhesus monkeys (N=9) were trained to respond under a fixed-ratio 10 schedule of food presentation. The effects of CP 55 940 (1.0-10 μg/kg, i.v.) and THC (3.0-300 μg/kg, i.v.) on food-maintained responding and body temperature were determined in these subjects prior to giving them access to self-administer each drug. Both drugs dose-dependently decreased food-maintained responding. CP 55 940 (0.001-3.0 μg/kg) functioned as a reinforcer in three monkeys, whereas THC (0.01-10 μg/kg) did not have reinforcing effects in any subject. CP 55 940 was least potent to decrease food-maintained responding in the monkeys in which CP 55 940 functioned as a reinforcer. Next, THC was administered daily to monkeys until tolerance developed to rate-decreasing effects. When THC SA was reexamined, it functioned as a reinforcer in three monkeys. In a group of cocaine-experienced male cynomolgus monkeys (N=4), THC SA was examined under a second-order schedule of reinforcement; THC functioned as reinforcer in two monkeys. These data suggest that SA of CBR agonists may be relatively independent of their rate-decreasing effects in Old World monkeys. Understanding individual differences in vulnerability to THC SA may lead to novel treatment strategies for marijuana abuse.
大麻的主要活性成分Δ-四氢大麻酚(THC)的强化作用,通过自我给药(SA)评估,仅在新大陆灵长类动物(松鼠猴)中得到证实。本研究的目的是调查一些实验因素,这些因素可能增强旧大陆猴(恒河猴和食蟹猴)对THC和大麻素受体(CBR)激动剂CP 55940的静脉自我给药,这是一种在生物医学研究中广泛使用的物种。在一项实验中,雄性恒河猴(N = 9)接受训练,在固定比率为10的食物呈现时间表下做出反应。在让这些受试者能够自我给药每种药物之前,测定了CP 55940(1.0 - 10μg/kg,静脉注射)和THC(3.0 - 300μg/kg,静脉注射)对食物维持反应和体温的影响。两种药物均剂量依赖性地降低了食物维持反应。CP 55940(0.001 - 3.0μg/kg)在三只猴子中起到了强化物的作用,而THC(0.01 - 10μg/kg)在任何受试者中都没有强化作用。在CP 55940起到强化物作用的猴子中,CP 55940降低食物维持反应的效力最低。接下来,每天给猴子注射THC,直到对其降低反应率的作用产生耐受性。当重新检查THC的自我给药时,它在三只猴子中起到了强化物的作用。在一组有可卡因使用经验的雄性食蟹猴(N = 4)中,根据二级强化时间表检查了THC的自我给药;THC在两只猴子中起到了强化物的作用。这些数据表明,在旧大陆猴中,CBR激动剂的自我给药可能相对独立于它们的降低反应率的作用。了解对THC自我给药易感性的个体差异可能会导致针对大麻滥用的新治疗策略。